1. Home
  2. JAZZ vs JHX Comparison

JAZZ vs JHX Comparison

Compare JAZZ & JHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$180.50

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Logo James Hardie Industries plc (Ireland)

JHX

James Hardie Industries plc (Ireland)

HOLD

Current Price

$20.22

Market Cap

11.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAZZ
JHX
Founded
2003
1888
Country
Ireland
Ireland
Employees
N/A
5860
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
11.4B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
JAZZ
JHX
Price
$180.50
$20.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
9
Target Price
$215.92
$28.50
AVG Volume (30 Days)
966.4K
4.8M
Earning Date
05-05-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,618,693,000.00
N/A
Revenue This Year
$6.17
$25.60
Revenue Next Year
$7.66
$15.24
P/E Ratio
N/A
$122.05
Revenue Growth
N/A
N/A
52 Week Low
$95.49
$16.46
52 Week High
$198.00
$29.83

Technical Indicators

Market Signals
Indicator
JAZZ
JHX
Relative Strength Index (RSI) 52.38 33.66
Support Level $176.67 $18.98
Resistance Level $182.99 $20.95
Average True Range (ATR) 4.97 0.66
MACD -1.09 -0.30
Stochastic Oscillator 25.88 18.16

Price Performance

Historical Comparison
JAZZ
JHX

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About JHX James Hardie Industries plc (Ireland)

James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.

Share on Social Networks: